Throughout the COVID-19 pandemic, Saint Luke’s Health System is committed to providing exceptional care for all patients and a safe and healthy atmosphere for our team.

A review of data obtained from within the DISCOVER registry is offering clinicians insight into the prevalence of GLP-1 receptor agonists and SGLT2 inhibitors.

Presented at American Diabetes Association's 81st Scientific Sessions, information from the registry describes a slow, but gradual uptake in SGLT2 inhibitors but also outlines gaps in prescribing that leave many patients who could benefit the most without these medications.

Endocrinology Network talked to Dr. Suzanne Arnold, cardiologist at Saint Luke's Mid America Heart Institute, about the DISCOVER registry and the take-home message of its findings.

Read the full Endocrinology Network article: DISCOVER Details Gradual Uptake, Need for Improvement in Prescribing of SGLT2 Inhibitors, GLP-1 RAs

Read more >

Related Content

Person, Hair, Nurse, Face, Female, Word
Nicole's story

"What we do is so vital. We have so much power as nurses." Nicole Roberson, Registered Nurse, Neuroscience ICU, Saint Luke's Hospital of Kansas City

Read more >
Person, Doctor, Clothing, Apparel, Lab Coat, Coat, Face, Nurse
Deb's story

Deb Day, Registered Nurse · Anderson County Hospital "I am a Saint Luke's Nurse.  Nurses are the lifeblood of Saint Luke’s compassionate care, and the life-changing work they do is...

Read more >
Apparel, Clothing, Coat, Lab Coat, Person, Doctor
Danielle's story

"You get those rare moments that you're reminded why you went into this field, and it makes everything so much better." Danielle Hammontree, Certified Family Nurse Practitioner, Saint Luke’s East Hospital

Read more >